Literature DB >> 8743487

Role of atrial natriuretic factor in volume control.

T Maack1.   

Abstract

Atrial natriuretic factor (ANF) is a 28 amino acid polypeptide hormone secreted mainly by the heart atria in response to atrial stretch. ANF acts on the kidney to increase sodium excretion and GFR, to antagonize renal vasoconstriction, and to inhibit renin secretion. In the cardiovascular system, ANF antagonizes vasoconstriction, and shifts fluid from the intravascular to the interstitial compartment. In the adrenal gland, ANF is a powerful inhibitor of aldosterone synthesis. ANF participates importantly in the natriuretic response to acute and chronic volume overload. ANF's property of shifting fluid from the vascular to the interstitial compartment acts as a buffering device, guarding against excessive plasma volume expansion in face of an increased total extracellular fluid volume. ANF is also a physiological modulator of GFR, and mediates nephron hyperfiltration and natriuresis when salt excretion is threatened by a reduction in the number of nephrons. Guanylyl cyclase (GCA) receptors mediate the effects of ANF by generating cGMP. Clearance receptors remove ANF from the circulation by receptor-mediated endocytosis, and serve as a hormone buffer system to impede large inappropriate fluctuations in plasma levels of ANF. The specific structure-function-dynamics relationships of these receptors serve to modulate the role of ANF in pressure-volume homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743487     DOI: 10.1038/ki.1996.257

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  Reciprocal regulation of human soluble and particulate guanylate cyclases in vivo.

Authors:  M Madhani; M Okorie; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

2.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 3.  Integrated control of Na transport along the nephron.

Authors:  Lawrence G Palmer; Jürgen Schnermann
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-06       Impact factor: 8.237

4.  Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice.

Authors:  Matthew R Alexander; Joshua W Knowles; Toshio Nishikimi; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-17       Impact factor: 8.311

5.  Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community.

Authors:  Wolfgang Lieb; Michael J Pencina; Paul F Jacques; Thomas J Wang; Martin G Larson; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2011-02-11

6.  Clathrin-dependent internalization, signaling, and metabolic processing of guanylyl cyclase/natriuretic peptide receptor-A.

Authors:  Naveen K Somanna; Indra Mani; Satyabha Tripathi; Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2017-09-12       Impact factor: 3.396

7.  Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury.

Authors:  Melanie Madhani; Andrew R Hall; Friederike Cuello; Rebecca L Charles; Joseph R Burgoyne; William Fuller; Adrian J Hobbs; Michael J Shattock; Philip Eaton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

8.  Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif.

Authors:  Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2009-11-26       Impact factor: 3.396

9.  Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.

Authors:  Melanie Madhani; Ramona S Scotland; Raymond J MacAllister; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.

Authors:  Sharmila D Chauhan; Holger Nilsson; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.